Clinical Trial Update: A Trial of SHR-A2102 for Treatment of Advanced Gynecological Malignancy [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study of SHR-A2102 for advanced gynecologic malignancies and indicates that recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gynecologic Cancer

Drugs mentioned

• SHR-A2102

Snippet

Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. | Conditions: Advanced Gynecological Malignancy | Phase 2 | Status: RECRUITING